| Labcorp

September 1, 2020

LabCorp is scheduled to present at the Baird’s 2020 Global Healthcare conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 1, 2020-- LabCorp (NYSE: LH) today announced that members of the executive management team will participate in a virtual fireside chat at the Baird’s 2020 Global Healthcare Conference on Wednesday, Sept. 9 at 11:25 a.m. ET.

August 26, 2020

Media Statement: Labcorp has performed more than 12 million molecular tests to date: Reduces results delivery time to 1-2 days on average from specimen pickup

Labcorp has surpassed 12 million molecular tests performed since first making our COVID-19 test available in March.

August 19, 2020

Media Statement: Labcorp increases capacity for molecular tests to 200,000 per day: Continues to deliver results in 1-3 days on average from specimen pickup

LabCorp has increased COVID-19 molecular testing capacity to 200,000 per day as part of our ongoing commitment to expand capacity to meet testing needs, though volumes received are currently below that number.

Managing Your Health

Diseases & Therapeutic Areas

Treatment Modalities & Methods

Scientific Lab Disciplines

Labs

Industries

LabCorp is scheduled to present at the Baird’s 2020 Global Healthcare conference

Labcorp Is Scheduled to Present at the Baird’s 2020 Global Healthcare Conference

Media Statement: Labcorp has performed more than 12 million molecular tests to date: Reduces results delivery time to 1-2 days on average from specimen pickup

Media Statement: Labcorp increases capacity for molecular tests to 200,000 per day: Continues to deliver results in 1-3 days on average from specimen pickup